Citation Impact
3 standout
Citing Papers
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Chimeric antigen receptor T cell therapy for autoimmune disease
2024 Standout
Works of K. Humphrey being referenced
GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B‐CELL LYMPHOMA (LBCL): EXTENDED FOLLOW‐UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY
2023
P1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
2022
Author Peers
| Author | PFM | Oncology | PHEOH | RNMI | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| K. Humphrey | 29 | 20 | 4 | 13 | 17 | 42 | |
| P. Tanghøj | 2 | 2 | 21 | 5 | 18 | 635 | |
| Weifang Tang | 37 | 77 | 4 | 8 | 47 | 1.0k | |
| Hosam Ghazy Elbanna | 11 | 60 | 2 | 2 | 20 | 308 | |
| Shaun Bullett | 1 | 1 | 33 | 302 | |||
| Thorsten Rische | 6 | 1 | 12 | 854 |
All Works
Login with ORCID to disown or claim papers
Loading papers...